Ims Capital Management Pfizer Inc Transaction History

Ims Capital Management

$212 Million
Q4 2024

A detailed history of Ims Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Ims Capital Management holds 103,791 shares of PFE stock, worth $2.72 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

103,791

Previous 104,390 0.57%

Holding current value

$2.72 Million

Previous $3.02 Million 8.87%

% of portfolio

1.3%

Previous 1.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$24.8 - $30.19 $14,855 - $18,083	-599 Reduced 0.57%	103,791 $2.75 Million
Q3 2024 Dec 17, 2024	SELL	$27.7 - $31.39 $15,179 - $17,201	-548 Reduced 0.52%	104,390 $3.02 Million
Q2 2024 Aug 21, 2024	BUY	$25.26 - $29.6 $51,252 - $60,058	2,029 Added 1.97%	104,938 $2.94 Million
Q1 2024 Jun 12, 2024	BUY	$25.89 - $29.73 $86,084 - $98,852	3,325 Added 3.34%	102,909 $2.86 Million
Q4 2023 Apr 01, 2024	BUY	$26.13 - $33.94 $458,947 - $596,122	17,564 Added 21.41%	99,584 $2.87 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $24,067 - $28,132	750 Added 0.92%	82,020 $2.72 Million
Q2 2023 Sep 13, 2023	BUY	$36.12 - $41.79 $530,386 - $613,644	14,684 Added 22.05%	81,270 $2.98 Million
Q1 2023 Sep 13, 2023	BUY	$39.39 - $51.28 $19,182 - $24,973	487 Added 0.74%	66,586 $2.72 Million
Q4 2022 Feb 22, 2023	BUY	$41.75 - $54.5 $6,471 - $8,447	155 Added 0.24%	66,099 $3.39 Million
Q3 2022 Nov 17, 2022	BUY	$43.76 - $53.42 $35,445 - $43,270	810 Added 1.24%	65,944 $2.89 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $2.48 Million - $2.94 Million	53,321 Added 451.38%	65,134 $3.42 Million
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $35,913 - $44,501	785 Added 7.12%	11,813 $612,000
Q4 2021 Jan 05, 2022	BUY	$41.32 - $61.25 $49,749 - $73,745	1,204 Added 12.26%	11,028 $651,000
Q3 2021 Oct 07, 2021	BUY	$39.25 - $50.42 $33,558 - $43,109	855 Added 9.53%	9,824 $423,000
Q2 2021 Jul 07, 2021	SELL	$35.91 - $40.68 $1,041 - $1,179	-29 Reduced 0.32%	8,969 $351,000
Q1 2021 Apr 22, 2021	SELL	$33.49 - $37.77 $165,206 - $186,319	-4,933 Reduced 35.41%	8,998 $326,000
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $208,551 - $265,191	-6,231 Reduced 30.9%	13,931 $513,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $205,994 - $241,678	-6,488 Reduced 24.35%	20,162 $740,000
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $55,993 - $67,927	1,859 Added 7.5%	26,650 $871,000
Q1 2020 Apr 03, 2020	BUY	$27.03 - $38.62 $478,268 - $683,342	17,694 Added 249.32%	24,791 $809,000
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $131 - $149	4 Added 0.06%	7,097 $278,000
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $24,367 - $31,597	750 Added 11.82%	7,093 $255,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $56,838 - $63,816	-1,537 Reduced 19.51%	6,343 $275,000
Q1 2019 May 21, 2019	BUY	$37.5 - $41.2 $64,237 - $70,575	1,713 Added 27.78%	7,880 $335,000
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $100,637 - $114,737	-2,616 Reduced 29.78%	6,167 $269,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $106,167 - $128,774	3,080 Added 54.01%	8,783 $0
Q2 2018 Jul 26, 2018	SELL	$32.98 - $35.16 $48,876 - $52,107	-1,482 Reduced 20.63%	5,703 $207,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $27,705 - $29,396	833 Added 13.11%	7,185 $260,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $196,912 - $216,920	6,352	6,352 $227,000

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.

Account

Ims Capital Management Pfizer Inc Transaction History